Mitoxantrone (INN, BAN, USAN; also known as Mitozantrone in Australia; trade name Novantrone) is an anthracenedione antineoplastic agent. Mitoxantrone...
7 KB (537 words) - 13:28, 29 May 2024
Uramustine Aclarubicin Daunorubicin Doxorubicin Epirubicin Idarubicin Mitoxantrone Pirarubicin Valrubicin Zorubicin Abraxane Cabazitaxel Docetaxel Larotaxel...
5 KB (313 words) - 21:41, 30 March 2024
often daunorubicin (can be substituted for doxorubicin or idarubicin or mitoxantrone). There were attempts to intensify the "7+3" regimen in order to try...
4 KB (472 words) - 02:59, 5 June 2022
and in combination with other agents including etoposide, fludarabine, mitoxantrone, methotrexate, prednisone, rituximab, vincristine and 90Y-ibritumomab...
14 KB (1,239 words) - 21:21, 2 March 2024
Multiple sclerosis drug pipeline (section Mitoxantrone)
and RPMS (rapidly progressive) Primary progressive: Ocrelizumab and mitoxantrone are the only approved drugs for PPMS. The last with restrictions. Secondary...
83 KB (9,414 words) - 17:06, 8 June 2024
is an experimental antineoplastic (anti-cancer) drug, an analogue of mitoxantrone with fewer toxic effects on cardiac tissue. It acts as a topoisomerase...
19 KB (1,944 words) - 22:06, 11 September 2021
overall survival (OS) is markedly enhanced with cabazitaxel versus mitoxantrone after prior docetaxel treatment. FIRSTANA (ClinicalTrials.gov identifier:...
12 KB (947 words) - 23:39, 23 March 2024
PMID 12740686. S2CID 41656726. Clinical trial number NCT00004071 for "Mitoxantrone and Prednisone With or Without Leflunomide in Treating Patients With...
22 KB (1,877 words) - 17:11, 24 February 2024
2011, mitoxantrone was the first medication approved for secondary progressive MS. In this population, tentative evidence supports mitoxantrone moderately...
164 KB (17,356 words) - 19:52, 16 June 2024
in methylammonium lead halides MA (chemotherapy) is an acronym for Mitoxantrone + standard-dose Ara-C (cytarabine) chemotherapy regimen Marijuana Anonymous...
7 KB (947 words) - 09:42, 29 March 2024